GenFleet Therapeutics Buys Back 20,000 H-Shares for HKD 0.55 Million, Lifting Treasury Stock to 59,000 Shares

Bulletin Express09-03

GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B) disclosed a share repurchase of 20,000 H-shares on 3 September 2026. The shares were acquired on the Hong Kong Stock Exchange at a single price of HKD 27.32 per share, representing an outlay of HKD 0.55 million and equivalent to 0.006 % of the company’s issued share capital (excluding treasury shares) before the transaction.

Following the buyback, the company’s outstanding share count decreased to 351.57 million, while treasury shares increased to 59,000. Total issued shares, including treasury stock, remain unchanged at 351.63 million.

The repurchase forms part of the mandate approved on 11 May 2026, which authorises the company to buy back up to 37.04 million shares. Cumulative purchases under this mandate now stand at 59,000 shares, representing 0.016 % of the issued share base on the mandate date.

In accordance with Hong Kong Listing Rules, GenFleet Therapeutics is subject to a moratorium on issuing, selling, or transferring shares for 30 days following the repurchase, ending on 3 October 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1145403437?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-03 19:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1145403437","market":"us","top_or_hot":-1,"title":"GenFleet Therapeutics Buys Back 20,000 H-Shares for HKD 0.55 Million, Lifting Treasury Stock to 59,000 Shares","media":"Bulletin Express","content":"<p>GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B) disclosed a share repurchase of 20,000 H-shares on 3 September 2026. The shares were acquired on the Hong Kong Stock Exchange at a single price of HKD 27.32 per share, representing an outlay of HKD 0.55 million and equivalent to 0.006 % of the company’s issued share capital (excluding treasury shares) before the transaction.</p>\n<p>Following the buyback, the company’s outstanding share count decreased to 351.57 million, while treasury shares increased to 59,000. Total issued shares, including treasury stock, remain unchanged at 351.63 million.</p>\n<p>The repurchase forms part of the mandate approved on 11 May 2026, which authorises the company to buy back up to 37.04 million shares. Cumulative purchases under this mandate now stand at 59,000 shares, representing 0.016 % of the issued share base on the mandate date.</p>\n<p>In accordance with Hong Kong Listing Rules, GenFleet Therapeutics is subject to a moratorium on issuing, selling, or transferring shares for 30 days following the repurchase, ending on 3 October 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GenFleet Therapeutics Buys Back 20,000 H-Shares for HKD 0.55 Million, Lifting Treasury Stock to 59,000 Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenFleet Therapeutics Buys Back 20,000 H-Shares for HKD 0.55 Million, Lifting Treasury Stock to 59,000 Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-03 19:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B) disclosed a share repurchase of 20,000 H-shares on 3 September 2026. The shares were acquired on the Hong Kong Stock Exchange at a single price of HKD 27.32 per share, representing an outlay of HKD 0.55 million and equivalent to 0.006 % of the company’s issued share capital (excluding treasury shares) before the transaction.</p>\n<p>Following the buyback, the company’s outstanding share count decreased to 351.57 million, while treasury shares increased to 59,000. Total issued shares, including treasury stock, remain unchanged at 351.63 million.</p>\n<p>The repurchase forms part of the mandate approved on 11 May 2026, which authorises the company to buy back up to 37.04 million shares. Cumulative purchases under this mandate now stand at 59,000 shares, representing 0.016 % of the issued share base on the mandate date.</p>\n<p>In accordance with Hong Kong Listing Rules, GenFleet Therapeutics is subject to a moratorium on issuing, selling, or transferring shares for 30 days following the repurchase, ending on 3 October 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02595","symbol_name":"劲方医药-B","start_time":0,"source_url":"","article_id":"1145403437","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1145403437","pubTimestamp":1788435803,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B) disclosed a share repurchase of 20,000 H-shares on 3 September 2026. The shares were acquired on the Hong Kong Stock Exchange at a single price of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02595":"劲方医药-B"},"translate_title":"GenFleet Therapeutics以55万港元回购2万股H股，库存股增至5.9万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02595":1},"content_text":"GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B) disclosed a share repurchase of 20,000 H-shares on 3 September 2026. The shares were acquired on the Hong Kong Stock Exchange at a single price of HKD 27.32 per share, representing an outlay of HKD 0.55 million and equivalent to 0.006 % of the company’s issued share capital (excluding treasury shares) before the transaction.\nFollowing the buyback, the company’s outstanding share count decreased to 351.57 million, while treasury shares increased to 59,000. Total issued shares, including treasury stock, remain unchanged at 351.63 million.\nThe repurchase forms part of the mandate approved on 11 May 2026, which authorises the company to buy back up to 37.04 million shares. Cumulative purchases under this mandate now stand at 59,000 shares, representing 0.016 % of the issued share base on the mandate date.\nIn accordance with Hong Kong Listing Rules, GenFleet Therapeutics is subject to a moratorium on issuing, selling, or transferring shares for 30 days following the repurchase, ending on 3 October 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1145403437","isCrawlerRequest":true}